Article in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Ramona E WeberDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.ORCID 0000-0001-5110-270X
Kiana M SchulzeDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.ORCID 0000-0001-6467-5179
Andrew G HornDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.
Tyler E McCoachDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.
Zachary J WhiteDepartment of Anatomy & Physiology, Kansas State University, Manhattan, Kansas, USA.ORCID 0000-0002-2591-6002
K Sue HagemanDepartment of Anatomy & Physiology, Kansas State University, Manhattan, Kansas, USA.
Stephanie E HallDepartment of Anatomy & Physiology, Kansas State University, Manhattan, Kansas, USA.ORCID 0000-0001-8962-8475
Peter SandnerBayer HealthCare AG, Drug Discovery, Wuppertal, Germany.
Brad J BehnkeDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.
Timothy I MuschDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.
David C PooleDepartment of Kinesiology, Kansas State University, Manhattan, Kansas, USA.ORCID 0000-0003-2441-3793
Funding
DO HEART FAILURE AND AGING POTENTIATE DIAPHRAGM VASCULAR DYSFUNCTION?R15AG078060 · NIA · KANSAS STATE UNIVERSITY · PI BEHNKE, BRAD J, POOLE, DAVID C · 2021 to 2021
$456k
Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunctionF31HL170643 · NHLBI · KANSAS STATE UNIVERSITY · PI SCHULZE, KIANA MARIE · 2023 to 2024
$73k
ROLE OF ANGIOTENSIN-(1-7) AND DIAPHRAGM VASCULAR FUNCTION IN HEART FAILURE AND PROLONGED MECHANICAL VENTILATIONF31HL167618 · NHLBI · KANSAS STATE UNIVERSITY · PI HORN, ANDREW · 2023 to 2024
$72k
Bayer AG | Pharmaceuticals Bayer BG6342HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1F31HL167618-02HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1F31HL170643-02HHS | NIH | National Institute on Aging (NIA) 1R15AG078060KSU | College of Veterinary Medicine, Kansas State University (Kansas State University College of Veterinary Medicine) SMILE GrantKSU | Johnson Cancer Research Center, Kansas State University (JCRC)NHLBI NIH HHS F31 HL167618NHLBI NIH HHS F31 HL170643NIA NIH HHS R15 AG078060
6 · The paper itself
Abstract
Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%-49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF-associated exercise intolerance are limited. Nitric oxide (NO)-independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance skeletal muscle oxygenation (interstitial pressure of O
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction. · full record | OpenQuestion